Professional Issue
Ankylosing spondylitis: clinical update
Patricia Cornell RGN BSc (Hons),
Susan M Oliver RGN MSc,
Corresponding Author
Patricia Cornell RGN BSc (Hons)
Senior Rheumatology Practitioner
Poole Hospital NHS Trust, Poole, Dorset
Poole Hospital NHS Trust, Longfleet Road, Poole, Dorset BH15 2JB.Search for more papers by this authorSusan M Oliver RGN MSc
Independent Nurse Specialist
Rheumatology
Search for more papers by this authorPatricia Cornell RGN BSc (Hons),
Susan M Oliver RGN MSc,
Corresponding Author
Patricia Cornell RGN BSc (Hons)
Senior Rheumatology Practitioner
Poole Hospital NHS Trust, Poole, Dorset
Poole Hospital NHS Trust, Longfleet Road, Poole, Dorset BH15 2JB.Search for more papers by this authorSusan M Oliver RGN MSc
Independent Nurse Specialist
Rheumatology
Search for more papers by this author
References
- Basmajan JV (1987). Therapeutic exercise in the management of rheumatic diseases. Journal of Rheumatology 14(Supp 5): 22–5.
- Boonan A, van de Heijde D, Londewe R, Guillemin F, Rutter-van Molken M et al (2003). Direct costs of ankylosing spondylitis and its determinants: An analysis among three European countries. Annals of Rheumatic Diseases 62: 732–40.
- Braun J et al (2003). International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Annals of Rheumatic Diseases 62(9): 817–24.
- Calin A (1991). AS and other inflammatory disorders of the spine. In P Schlapback (ed.) Physiotherapy: Controlled Trials and Facts. Basle: Karger, pp 82–92.
- Calin A (1995). The individual with ankylosing spondylitis: Defining disease status and the impact of the illness. Journal of Rheumatology 34: 663–72.
- Calin A (1998). Ankylosing spondylitis In PJ Maddison, D Isenberg, P Woo, D Glass (eds.) Oxford Textbook of Rheumatology ( 2nd edn.) Oxford: Oxford University Press.
- Calin A et al (1994). A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index (BASFI). Journal of Rheumatology 21: 2281–5.
- Chorus AMJ, Miedema HS, Boonen A, van der Linden SJ (2003). Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Annals of Rheumatic Diseases 62(12): 1178–84.
- Coles L et al (1983). From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugs. American Journal of Medicine 74: 820–8.
- Cornell P (2004) Clinical update on ankylosing spondylitis. Professional Nurse 19(8): 431–2.
- Cronan T et al (1997). The effects of social support and education interventions on health care costs. Arthritis Care and Research 10(2): 99–110.
- Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W (2003). Recombinant human tumour necrosis factor receptor (etanercept) for treating ankylosing spondylitis. Arthritis and Rheumatism 48(11): 3230–6.
- Dernis-Labous E, Messow M, Dougados M (2003). Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology 42: 1523–8.
- Doran MF, Brophy S, Mackay K, Taylor G, Calin A (2003). Predictors of longterm outcome in ankylosing spondylitis. Journal of Rheumatology 203(30): 316–20.
- Dougados M et al (1995). A randomised, multicenter, double-blind, placebo-controlled study. Arthritis and Rheumatism 38: 618–27.
- Dougados M et al (1999). Ankylosing spondylitis: What is the optimal duration of a clinical study? A one year versus 6 weeks nonsteriodal anti-inflammatory drug trial. Rheumatology 38: 235–44.
- Doward LC, Spoorenberg A, Cook SA et al (2003). Development of ASQOL; a quality of life instrument specific to ankylosing spondylitis. Annals of the Rheumatic Diseases 62: 20–6.
- Ferraz M et al (1990). Meta-analysis of sulfasalazine in ankylosing spondylitis. Journal of Rheumatology 17(11): 1482–6.
- Garret S et al (1994). A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Journal of Rheumatology 21: 2286–91.
- Jenkinson TR et al (1994). Defining spinal mobility in ankylosing spondylitis (AS): The Bath AS metrology index. Journal of Rheumatology 21: 1694–8.
- Jones SD et al (1996). The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). British Journal of Rheumatology 35: 66–71.
- Keat A (1996) Spondyloarthropathies In M Snaith (ed.) ABC of Rheumatology ( 3rd edn.) London: BMJ Publishing Group.
- Khan MA (2002a). Update on spondyloarthropathies. Annals of Internal Medicine 135: 896–907.
10.7326/0003-4819-136-12-200206180-00011 Google Scholar
- Khan MA (2002b). Ankylosing Spondylitis – The facts. Oxford: Oxford University Press.
- Marshall R, Kirwin J (2001). Methotrexate in the treatment of ankylosing spondylitis. Scandinavian Journal of Rheumatology 30: 313–14.
- Mukherjee D (2001). Risk of cardiovascular events associated with selected COX-2 inhibitors. Journal of the American Medical Association 286: 954–9.
- Oliver S, Mooney J (2002). Targeted therapies for patients with rheumatoid arthritis. Professional Nurse 17(12): 716–20.
- Oostveen J, Prevo R, den Boer J, van der Laar M (1999). Early detection of sacroiliitis on magnetic resonance imaging and subsequent devlopement of sacroiliitis on plain radiography. A prospective, longitudinal study. Journal of Rheumatology 26: 1953–8.
- Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002). Ankylosing spondylitis: An overview. Annals of Rheumatic Diseases 61(Suppl 3): iii8–18.
- Simon L et al (1999). Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomised controlled trial. Journal of the American Medical Association. 284: 1247–55.
- Taylor HG, Wardle T, Beswick FJ, Dawes PT (1991). The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Journal of Rheumatology 26: 966–70.
- Temekonidis TL, Alamanos Y, Bougias DV, Georgiadis AN, Voulgari PV, Drosos AA (2003). Infliximab therapy in patients with ankylosing spondylitis: An open label 12 months study. Annals of Rheumatic Diseases 62(11): 1218–20.
- Van der Heijde D, Braun J, McGonagle D, Siegel J (2002). Treatment trials in ankylosing spondylitis: Current and future considerations. Annals of Rheumatic Diseases 61(Suppl lll): iii24–32.
10.1136/ard.61.suppl_3.iii24 Google Scholar
- Van der Linden S, Valkenburg HA, Cats A (1984). Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis and Rheumatism 27: 361–8.
- Viitanen JV, Suni J (1995). Management principles of physiotherapy in ankylosing spondylitis – Which treatments are effective? Physiotherapy 81(6): 322–9.
10.1016/S0031-9406(05)66792-2 Google Scholar
- Ward MM (1999). Health related quality of life in ankylosing spondylitis: A survey of 175 patients. Arthritis Care Research 12(4): 247–55.
- Yunus M (1988). Current therapeutic practices in spondyloarthropathies: Comprehensive Therapy 14(2): 52–64.
Citing Literature
